Exclusive

Publication

Byline

Clinical Trial: Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740330) titled 'Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery' on July ... Read More


Clinical Trial: IKS04 Regimen in Advanced Solid Tumors That Express CA242

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738939) titled 'IKS04 Regimen in Advanced Solid Tumors That Express CA242' on July 23. Brief Summary: This ... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More


Clinical Trial: Multimodal Tracking of Therapy Activity and Effort During Rehabilitation

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739134) titled 'Multimodal Tracking of Therapy Activity and Effort During Rehabilitation' on July 27. Brief... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More


Clinical Trial: A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740161) titled 'A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility' on Ju... Read More


Clinical Trial: TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740499) titled 'TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Dise... Read More